ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 196

Dependence on Walking Aids Is Associated with Pain and Mobility Limitation after Total Hip Arthroplasty

Jasvinder A. Singh1 and David Lewallen2, 1University of Alabama and VA Medical Center, Birmingham, AL, 2Orthopedics, Mayo Clinic college of medicine, Rochester, MN

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Arthroplasty, functional status and outcomes, Hip

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Orthopedics, Low Back Pain and Rehabilitation

Session Type: Abstract Submissions (ACR)

Background/Purpose: To assess the association of dependence on walking aids with pain and function outcomes after total hip arthroplasty (THA).

Methods: We used the Mayo Clinic Total Joint Registry to study patients who underwent primary or revision THA between 1993-2005 and completed a 2-year or 5-year pain and function outcomes survey.  Multivariable-adjusted logistic regression assessed the associations, adjusting for clinical/demographic variables and preoperative pain and function.

Results: Primary THA cohort had 5,707 patients at 2-year and 3,289 at 5-years; revision THA included 2,667 patients at 2-year and 1,627 patients at 5-years.  Compared to patients with no dependence on walking aids, patients with some or complete dependence on walking aids had significantly higher odds (95% confidence interval) of: (1) moderate-severe pain post-primary THA at 2-years: 3.40 (2.06, 5.62) and 4.79 (2.88, 7.97); (2) moderate-severe pain post-primary THA at 5-years: 3.92 (2.21, 6.95) and 3.47 (1.97, 6.11); (3) moderate-severe pain post-revision THA at 2-years, 4.67 (2.76, 7.91) and 2.95 (1.65, 5.27); (4) moderate-severe pain post-revision THA at 5-years: 3.95 (1.86, 8.38) and 5.16 (2.59, 10.3); (5) moderate-severe mobility limitation post-primary THA at 2-years: 10.7 (6.78, 17.0) and 14.2 (8.32, 24.3); (6) moderate-severe mobility limitation post-primary THA at 5-years: 13.2 (7.34, 23.7) and 21.4 (10.6, 43.2); (7) moderate-severe mobility limitation post-revision THA at 2-years: 4.90 (2.87, 8.37) and 8.26 (4.12, 16.6); (8) moderate-severe mobility limitation post-revision THA at 5-years: 5.12 (2.32, 11.3) and 10.1 (4.53, 22.7), respectively.

Conclusion: Post-THA dependence on walking aids is associated with worse pain and function outcomes post-THA.


Disclosure:

J. A. Singh,

takeda, savient,

2,

takeda, savient, regeneron, allergan,

5;

D. Lewallen,

Zimmer, Orthosonic and Osteotech,

8,

Pipeline Biomedical ,

5,

DePuy, Stryker, Biomet and Zimmer.,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dependence-on-walking-aids-is-associated-with-pain-and-mobility-limitation-after-total-hip-arthroplasty/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology